Get startedLog in
    Picture of Rznomics logo

    476830 — Rznomics Income Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Rznomics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSPROSPECTUS
    Standards:
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinal
    Revenue
    Total Revenue01440
    Cost of Revenue
    Gross Profit—-3,708-2,770
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Other Operating Expenses
    Total Operating Expenses19,19115,66612,862
    Operating Profit-19,191-15,522-12,862
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-31,534-13,600-18,850
    Provision for Income Taxes
    Net Income After Taxes-31,534-13,600-18,850
    Net Income Before Extraordinary Items
    Net Income-31,534-13,600-18,850
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-31,534-13,600-18,850
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-2,292-989-1,370
    Dividends per Share